(Q57131263)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23744281%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

review article

1 reference

PubMed publication ID

23744281

title

The benefits and harms of breast cancer screening: an independent review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23744281%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

17 June 2019

breast cancer screening

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23744281%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

D G Altman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23744281%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

D A Cameron

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23744281%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

J A Dewar

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23744281%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

S G Thompson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23744281%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

M Wilcox

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23744281%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

language of work or name

English

0 references

publication date

6 June 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23744281%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Cancer

2 March 2020

published in

4 references

13 March 2019

3 April 2019

17 June 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23744281%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

108

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23744281%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23744281%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

2205-2240

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23744281%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported

2 March 2020

copyright license

3 references

13 March 2019

3 April 2019

on focus list of Wikimedia project

17 June 2019

copyright status

copyrighted

0 references

ScienceSource

0 references

exact match

https://scigraph.springernature.com/pub.10.1038/bjc.2013.177

0 references

cites work

Effect of screening and adjuvant therapy on mortality from breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

The 2009 breast cancer screening recommendations of the US Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

The number of women who would need to be screened regularly by mammography to prevent one death from breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Recommendations on screening for breast cancer in average-risk women aged 40-74 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Screening for breast cancer--balancing the debate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Screening for breast cancer: an update for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Breast cancer mortality in mammographic screening in Europe: a review of incidence-based mortality studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Long-term effects of mammography screening: updated overview of the Swedish randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Evidence for risk of bias in cluster randomised trials: review of recent trials published in three general medical journals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Effects of study methods and biases on estimates of invasive breast cancer overdetection with mammography screening: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Interpreting overdiagnosis estimates in population-based mammography screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Overdiagnosis in breast cancer screening: time to tackle an underappreciated harm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Rethinking screening for breast cancer and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Breast cancer screening: a 35-year perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

On the benefits and harms of screening for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Breast cancer screening for women ages 50 to 69 years a systematic review of observational evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Overdiagnosis in organised mammography screening in Denmark. A comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Overdiagnosis and overtreatment of breast cancer: overdiagnosis in randomised controlled trials of breast cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Overdiagnosis in breast cancer: design and methods of estimation in observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Comparison of the effects of genetic and environmental risk factors on in situ and invasive ductal breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Overdiagnosis from non-progressive cancer detected by screening mammography: stochastic simulation study with calibration to population based registry data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Evidence on screening for breast cancer from a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

The frequency of breast cancer screening: results from the UKCCCR Randomised Trial. United Kingdom Co-ordinating Committee on Cancer Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

The effect of DCIS grade on rate, type and time to recurrence after 15 years of follow-up of screen-detected DCIS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

21 January 2018

Overdiagnosis in cancer

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Ramifications of screening for breast cancer: 1 in 4 cancers detected by mammography are pseudocancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Long-term toxic effects of adjuvant chemotherapy in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Estimates of the potential risk of radiation-related cancer from screening in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Women who are recalled for further investigation for breast screening: psychological consequences 3 years after recall and factors affecting re-attendance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Moderate neutropenia with adjuvant CMF confers improved survival in early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Long term effects of tamoxifen on blood lipid values in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Risk of cardiac death after adjuvant radiotherapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Psychosocial aspects of mastectomy: I. the women's perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Predicting the impact of the screening programme for colorectal cancer in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

The cervical cancer epidemic that screening has prevented in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Radiation effects on breast cancer risk: a pooled analysis of eight cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Suicide after breast cancer: an international population-based study of 723,810 women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Suicides among Danish cancer patients 1971-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

A case-control study of the impact of the East Anglian breast screening programme on breast cancer mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Efficacy of breast cancer screening in the community according to risk level

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

A case-control study to estimate the impact on breast cancer death of the breast screening programme in Wales.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Case-control evaluation of breast cancer screening efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

A case-control study to estimate the impact of the Icelandic population-based mammography screening program on breast cancer death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Seventeen-year evaluation of breast cancer screening: the DOM project, The Netherlands. Diagnostisch Onderzoek (investigation) Mammacarcinoom

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

A case-control evaluation of the effect of breast cancer screening in the United Kingdom trial of early detection of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Protection of mammography screening against death from breast cancer in women aged 40-64 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Mammography screening and risk of breast cancer death: a population-based case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

A remarkable reduction of breast cancer deaths in screened versus unscreened women: a case-referent study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Time interval since last test in a breast cancer screening programme: a case-control study in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Effectiveness of service screening: a case-control study to assess breast cancer mortality reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Increasingly strong reduction in breast cancer mortality due to screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

The incidence of advanced breast cancer in the West Midlands, United Kingdom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Advanced breast cancer incidence following population-based mammographic screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Advanced breast cancer and breast cancer mortality in randomized controlled trials on mammography screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Mammography screening and breast cancer mortality in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Canadian National Breast Screening Study: assessment of technical quality by external review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Breast and other cancer dormancy as a therapeutic endpoint: speculative recombinant T cell receptor ligand (RTL) adjuvant therapy worth considering?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Published results on breast cancer and hormone replacement therapy in the Million Women Study are correct.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Model of outcomes of screening mammography: information to support informed choices

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Ovarian cancer and hormone replacement therapy in the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Commentary: screening mammography: a decision analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

The NHS breast screening programme needs independent review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Ketones and lactate "fuel" tumor growth and metastasis: Evidence that epithelial cancer cells use oxidative mitochondrial metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

The curability of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Biological characteristics of interval cancers: a role for biomarkers in the breast cancer screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Matrix remodeling stimulates stromal autophagy, "fueling" cancer cell mitochondrial metabolism and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Psychological consequences of screening mammography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Trends in breast cancer incidence, survival, and mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Digital mammography screening: weighing reduced mortality against increased overdiagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Pathological and biological differences between screen-detected and interval ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Complexities in the estimation of overdiagnosis in breast cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

The Swedish Two-County Trial of mammographic screening: cluster randomisation and end point evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Angiogenesis and vascular network of teratocarcinoma from embryonic stem cell transplant into seminiferous tubules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Solving the overdiagnosis dilemma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Impact of mammographic screening on the detection of good and poor prognosis breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

The case for early detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Psychosocial and sexual impact of diagnosis and treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Number needed to screen: appropriate use of this new basis for screening mammography guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

On the efficacy of screening for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Breast screening: the psychological sequelae of false-positive recall in women with and without a family history of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Communicating the balance sheet in breast cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Mammographic screening programmes in Europe: organization, coverage and participation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

The evidence base for breast cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Is the decrease in breast cancer incidence related to a decrease in postmenopausal hormone therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Hormone therapy and breast cancer risk 10 years after the WHI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

The breast screening programme and misinforming the public.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Why mammography screening has not lived up to expectations from the randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Height and cancer incidence in the Million Women Study: prospective cohort, and meta-analysis of prospective studies of height and total cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Reproductive factors and risk of oesophageal and gastric cancer in the Million Women Study cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Cost-effectiveness of different reading and referral strategies in mammography screening in the Netherlands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Effectiveness of the public health policy for breast cancer screening in Finland: population based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Measuring mortality reductions in cancer screening trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Breast cancer screening with mammography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

False-positive results in mammographic screening for breast cancer in Europe: a literature review and survey of service screening programmes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Flawed methods explain the effect of mammography screening in Nijmegen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Is the tide turning against breast screening?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Breast cancer mortality in organised mammography screening in Denmark: comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

An investigation of the apparent breast cancer epidemic in France: screening and incidence trends in birth cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Effect of Screening Mammography on Breast-Cancer Mortality in Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

An abnormal screening mammogram causes more anxiety than a palpable lump in benign breast disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Mammography activity in Norway 1983 to 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Effectiveness of mammography screening in reducing breast cancer mortality in women aged 39-49 years: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Impact of mammography detection on the course of breast cancer in women aged 40-49 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Modeling the impact of population screening on breast cancer mortality in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Breast cancer incidence and overdiagnosis in Catalonia (Spain)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Impact of false-positive mammography on subsequent screening attendance and risk of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Estimates of overdiagnosis of invasive breast cancer associated with screening mammography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Mammography screening and breast cancer mortality in Australia: an aggregate cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Inequalities in reported use of breast and cervical screening in Great Britain: analysis of cross sectional survey data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

The impact of mammographic screening on breast cancer mortality in Europe: a review of trend studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Trends in incidence and detection of advanced breast cancer at biennial screening mammography in The Netherlands: a population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Variation in the risk of radiation-related contralateral breast cancer by histology and estrogen receptor expression in SEER

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Overdiagnosis, sojourn time, and sensitivity in the Copenhagen mammography screening program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Estimate of overdiagnosis of breast cancer due to mammography after adjustment for lead time. A service screening study in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Overdiagnosis in screening: is the increase in breast cancer incidence rates a cause for concern?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

An estimate of overdiagnosis 15 years after the start of mammographic screening in Florence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Balancing harms and benefits of service mammography screening programs: a cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Breast cancer screening: are we seeing the benefit?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Possible net harms of breast cancer screening: updated modelling of Forrest report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

The decrease in breast-cancer incidence in 2003 in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Incidence of Breast Cancer and Its Subtypes in Relation to Individual and Multiple Low-Penetrance Genetic Susceptibility Loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Dormancy and surgery-driven escape from dormancy help explain some clinical features of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Breast cancer screening for women aged 40-49 years: screening may not be the benign process usually thought

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Mammography benefit in the Canadian National Breast Screening Study-2: a model evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

How effective are breast cancer screening programmes by mammography? Review of the current evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Screening and prostate-cancer mortality in a randomized European study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

The randomized trials of breast cancer screening: what have we learned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Comparison of screening mammography in the United States and the United kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Uninformed compliance or informed choice? A needed shift in our approach to cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Acute wounds accelerate tumorigenesis by a T cell-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Effect of mammography screening on surgical treatment for breast cancer in Norway: comparative analysis of cancer registry data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Mammography screening and breast cancer mortality in New South Wales, Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Five‐Hundred Life‐Saving Interventions and Their Cost‐Effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Gene-environment interactions in 7610 women with breast cancer: prospective evidence from the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Reduction in breast cancer mortality due to the introduction of mass screening in The Netherlands: comparison with the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Trends in invasive breast cancer incidence among French women not exposed to organized mammography screening: an age-period-cohort analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

UKCCCR multicentre randomised controlled trial of one and two view mammography in breast cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

The effect of mammographic screening and hormone replacement therapy use on breast cancer incidence in England and Wales

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Understanding recent trends in incidence of invasive breast cancer in Norway: age-period-cohort analysis based on registry data on mammography screening and hormone treatment use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Biennial versus annual mammography and the risk of late-stage breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Breast cancer dormancy can be maintained by small numbers of micrometastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Long-term incidence of breast cancer by trial arm in one county of the Swedish Two-County Trial of mammographic screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Improved survival rate for women with interval breast cancer - results from the breast cancer screening programme in Malmö, Sweden 1976-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Overdiagnosis of breast cancer after 14 years of mammography screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

The natural history of invasive breast cancers detected by screening mammography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Declining incidence of breast cancer after decreased use of hormone-replacement therapy: magnitude and time lags in different countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Psychological consequences of false-positive screening mammograms in the UK.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3693450

Mammography screening: truth, lies, and controversy

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3693450

Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3693450

Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3693450

Relation between breast cancer mortality and screening effectiveness: systematic review of the mammography trials

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3693450

Screening for breast cancer with mammography

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3693450

Approaches to improving breast screening uptake: evidence and experience from Tower Hamlets

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3693450

Screening for breast cancer with mammography

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3693450

Screening for breast cancer in England: past and future

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3693450

Ramifications of screening for breast cancer: overdiagnosis in the Malmö trial was considerably underestimated

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3693450

Evaluation of service screening mammography in practice: the impact on breast cancer mortality

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3693450

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3693450

Endometrial cancer and hormone-replacement therapy in the Million Women Study

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3693450

Misleading quotations and other errors persist in rejoinder on breast cancer screening.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3693450

Mammographic screening after the age of 65 years: evidence for a reduction in breast cancer mortality.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3693450

The costs and benefits of breast cancer screening

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3693450

Measuring effects without randomized trials? Options, problems, challenges.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3693450

Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3693450

Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3693450

Comparison of the coding of death certificates related to cancer in seven countries

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3693450

Population screening and intensity of screening are associated with reduced breast cancer mortality: evidence of efficacy of mammography screening in Australia

2 November 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

21 January 2018

Mammography screening

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Trends in cancer incidence and mortality

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3693450

Summary of the Evidence of Breast Cancer Service Screening Outcomes in Europe and First Estimate of the Benefit and Harm Balance Sheet

30 November 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

Ten- to fourteen-year effect of screening on breast cancer mortality

21 January 2018

1 reference

12 December 2020

Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen project, 1975-1981

1 reference

12 December 2020

Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of uncertain factors

1 reference

12 December 2020

The impact of a breast cancer screening programme on quality-adjusted life-years

1 reference

12 December 2020

Determination of cause of death among breast cancer cases in the Swedish randomized mammography screening trials. A comparison between official statistics and validation by an endpoint committee

1 reference

12 December 2020

The Swedish randomised mammography screening trials: analysis of their effect on the breast cancer related excess mortality

1 reference

12 December 2020

Recalling women for further investigation of breast screening: women's experiences at the clinic and afterwards

1 reference

12 December 2020

Adjusting for non-compliance and contamination in randomized clinical trials

1 reference

12 December 2020

Using autopsy series to estimate the disease "reservoir" for ductal carcinoma in situ of the breast: how much more breast cancer can we find?

1 reference

12 December 2020

Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population

1 reference

12 December 2020

Breast cancer screening: Evidence for false reassurance?

1 reference

12 December 2020

Evaluation of screening for breast cancer in a non-randomised study (the DOM project) by means of a case-control study

1 reference

12 December 2020

Mammographic screening and breast cancer mortality: age-specific effects in Nijmegen Project, 1975-82

1 reference

12 December 2020

Analysis of Breast Cancer Mortality and Stage Distribution by Age for the Health Insurance Plan Clinical Trial

1 reference

12 December 2020

Presence of a growth-stimulating factor in serum following primary tumor removal in mice

1 reference

12 December 2020

Evaluation of overdiagnosis of breast cancer in screening with mammography: results of the Nijmegen programme

1 reference

12 December 2020

Screening mammography

1 reference

12 December 2020

Case-control studies of screening procedures

1 reference

12 December 2020

Suicide attitude in breast cancer patients

1 reference

12 December 2020

Adjuvant therapy, not mammographic screening, accounts for most of the observed breast cancer specific mortality reductions in Australian women since the national screening program began in 1991

1 reference

12 December 2020

Does an organised screening programme reduce the inequalities in breast cancer survival?

1 reference

12 December 2020

Impressive time-related influence of the Dutch screening programme on breast cancer incidence and mortality, 1975-2006

1 reference

12 December 2020

Investigation of Design and Bias Issues in Case-Control Studies of Cancer Screening Using Microsimulation

1 reference

12 December 2020

Premenopausal status accelerates relapse in node positive breast cancer: hypothesis links angiogenesis, screening controversy

1 reference

12 December 2020

The controversy over breast cancer screening

1 reference

12 December 2020

Repeated mammographic screening reduces breast cancer mortality along the continuum of age

1 reference

12 December 2020

Non-attendance in breast cancer screening is associated with unfavourable socio-economic circumstances and advanced carcinoma

1 reference

12 December 2020

Screening mammography--a long run for a short slide?

1 reference

12 December 2020

Effective biennial mammographic screening in women aged 40-49

1 reference

12 December 2020

The Two-County Breast Screening Trial Cannot Provide a Reliable Estimate of the Effect of Breast Cancer Screening

1 reference

12 December 2020

Prognosis and pathology of screen-detected carcinomas

1 reference

12 December 2020

Empirical comparison of the results of randomized controlled trials and case-control studies in evaluating the effectiveness of screening mammography

1 reference

12 December 2020

Do women who undergo further investigation for breast screening suffer adverse psychological consequences? A multi-centre follow-up study comparing different breast screening result groups five months after their last breast screening appointment

1 reference

12 December 2020

14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening

1 reference

12 December 2020

Seventy-five years is an appropriate upper age limit for population-based mammography screening

1 reference

12 December 2020

Clarifying breast cancer risks associated with menopausal hormone therapy

1 reference

12 December 2020

Swedish Two-County Trial: Impact of Mammographic Screening on Breast Cancer Mortality during 3 Decades

1 reference

12 December 2020

The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up

1 reference

12 December 2020

Increased incidence of invasive breast cancer after the introduction of service screening with mammography in Sweden

1 reference

12 December 2020

Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study

1 reference

12 December 2020

Women in their 40s should not be screened for breast cancer, new Canadian guideline says

1 reference

12 December 2020

Is Mammographic Screening Justifiable Considering Its Substantial Overdiagnosis Rate and Minor Effect on Mortality?

1 reference

12 December 2020

Breast cancer screening: introduction

1 reference

12 December 2020

Breast cancer screening: commentary and conclusions

1 reference

12 December 2020

Commentary: a defence of the Health Insurance Plan (HIP) study and the Canadian National Breast Screening Study (CNBSS)

1 reference

12 December 2020

Commentary: false premises, false promises and false positives--the case against mammographic screening for breast cancer

1 reference

12 December 2020

Systematic review of the psychological consequences of false-positive screening mammograms

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2013.177

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/BJC.2013.177

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23744281%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23744281%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

PubMed publication ID

23744281

1 reference